drugset / Trial / NCT04897854

Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer

NCT04897854 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Since patients with metastatic pancreatic cancer have a limited life expectancy, it is important to determine the timing of when to start chemotherapy in order to optimize the benefits of chemotherapy relative to the side effects. Therefore, two treatment strategies can be considered: chemotherapy started immediately at diagnosis, or delayed until disease-related symptoms occur.

Timeline

Start
2021-04-22
Primary completion
2024-04-22
Completion
2024-04-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator FOLFIRINOX Unknown — —